These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Cutaneous squamous cell carcinomas are associated with basal proliferating actinic keratoses. Schmitz L; Gambichler T; Kost C; Gupta G; Stücker M; Stockfleth E; Dirschka T Br J Dermatol; 2019 Apr; 180(4):916-921. PubMed ID: 29526028 [TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of Ki67, P16 and Beta-catenin in precursor lesions of cutaneous squamous cell carcinoma. Vîlcea AM; Stoica LE; Andreiana BC; Mirea CS; Ţenea Cojan TŞ; Vîlcea IC; Mărgăritescu C Rom J Morphol Embryol; 2024; 65(1):19-25. PubMed ID: 38527980 [TBL] [Abstract][Full Text] [Related]
9. Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease. Talghini S; Halimi M; Baybordi H Pak J Biol Sci; 2009 Jun; 12(12):929-33. PubMed ID: 19777788 [TBL] [Abstract][Full Text] [Related]
10. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis. Lee JS; Park HS; Yoon HS; Cho S Clin Exp Dermatol; 2019 Jul; 44(5):483-490. PubMed ID: 30315595 [TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases. Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin. Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease. Bagazgoitia L; Cuevas J; Juarranz A J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):228-30. PubMed ID: 19515076 [TBL] [Abstract][Full Text] [Related]
14. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602 [TBL] [Abstract][Full Text] [Related]
15. Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin. Athanassiadou AM; Lazaris AC; Patsouris E; Tsipis A; Chelidonis G; Aroni K Am J Dermatopathol; 2013 Jun; 35(4):425-31. PubMed ID: 23095338 [TBL] [Abstract][Full Text] [Related]
16. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases. Karagece Yalçin U; Seçkın S Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA31 and MMP-1 contribute to the differentiated pathway of invasion -with enhanced epithelial-to-mesenchymal transition- in squamous cell carcinoma of the skin. Fernández-Figueras MT; Carrato C; Saenz-Sardà X; Musulén E; Fuente MJ; Puig L Arch Dermatol Res; 2022 Oct; 314(8):767-775. PubMed ID: 34647185 [TBL] [Abstract][Full Text] [Related]
19. [Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis]. Dornelas MT; Rodrigues MF; Machado DC; Gollner AM; Ferreira AP An Bras Dermatol; 2009; 84(5):469-75. PubMed ID: 20098848 [TBL] [Abstract][Full Text] [Related]
20. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms. Zhang X; Egawa K; Xie Y; Ihn H Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]